As a reminder, this all is in a petri dish: Ponatinib in NEUROBLASTOM. We have had over three YEARS, and no new new trials. It would take 8 years to approval. Ariad has announced they are placing their limited resources elsewhere, otherwise these human trial would have started..
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.